Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: An update

American Journal of Pathology

Volumn 175, Issue 5, 2009, Pages 1790-1798

  Gómez Puerta, José A ^a   Bosch, Xavier ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

AUTOIMMUNITY; BLOOD VESSEL INJURY; CELL INTERACTION; CLINICAL FEATURE; CROSS REACTION; DISEASE CLASSIFICATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SMALL VESSEL VASCULITIS; T LYMPHOCYTE;

EID: 73649129894     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090533     Document Type: Review

References (62)

1. Davies DJ, Moran JE, Niall JF, Ryan GB: Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J (Clin Res Ed) 1982, 285:606
2. van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH: autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985, 1:425-429
3. Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988, 318:1651-1657
4. Jenne DE, Tschopp J, Ludemann J, Utecht B, Gross WL: Wegener's autoantigen decoded. Nature 1990, 346:520
5. Jennette JC, Hoidal JR, Falk RJ: Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 1990, 75:2263-2264
6. Seo P, Stone JH: The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 2004, 117:39-50
7. Jennette JC, Falk RJ: Small-vessel vasculitis. N Engl J Med 1997, 337:1512-1523
8. Mansi IA, Opran A, Rosner F: ANCA-associated small-vessel vasculitis. Am Fam Physician 2002, 65:1615-1620
9. Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot RW Jr, Masi AT, et al.: The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990, 33:1065-1067
10. Bosch X, Guilabert A, Font J: Antineutrophil cytoplasmic antibodies. Lancet 2006, 368:404-418
11. Keogh KA, Specks U: Churg-Strauss syndrome. Semin Respir Crit Care Med 2006, 27:148-157
12. Pagnoux C, Guilpain P, Guillevin L: Churg-Strauss syndrome. Curr Opin Rheumatol 2007, 19:25-32
13. Hellmich B, Csernok E, Gross WL: Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome. Ann NY Acad Sci 2005, 1051:121-131
14. Kallenberg CG: Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Curr Opin Rheumatol 2007, 19:17-24
15. Vaglio A, Martorana D, Maggiore U, Grasselli C, Zanetti A, Pesci A, Garini G, Manganelli P, Bottero P, Tumiati B, Sinico RA, Savi M, Buzio C, Neri TM: HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum 2007, 56:3159-3166
16. Little MA, Smyth CL, Yadav R, Ambrose L, Cook HT, Nourshargh S, Pusey CD: Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 2005, 106:2050-2058
17. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002, 110:955-963
18. Pfister H, Ollert M, Frohlich LF, Quintanilla-Martinez L, Colby TV, Specks U, Jenne DE: Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood 2004, 104:1411-1418
19. Huugen D, Xiao H, van Esch A, Falk RJ, Peutz-Kootstra CJ, Buurman WA, Tervaert JW, Jennette JC, Heeringa P: Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-α. Am J Pathol 2005, 167:47-58
20. Xiao H, Heeringa P, Liu Z, Huugen D, Hu P, Maeda N, Falk RJ, Jennette JC: The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 2005, 167:39-45
21. Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC: Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 2007, 170:52-64
22. + cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis. J Am Soc Nephrol 2006, 17:1940-1949
23. Huugen D, van Esch A, Xiao H, Peutz-Kootstra CJ, Buurman WA, Tervaert JW, Jennette JC, Heeringa P: Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int 2007, 71:646-654
24. Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, Grone HJ, Brinkmann V, Jenne DE: Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 2009, 15:623-625
25. Kain R, Exner M, Brandes R, Ziebermayr R, Cunningham D, Alderson CA, Davidovits A, Raab I, Jahn R, Ashour O, Spitzauer S, Sunder-Plassmann G, Fukuda M, Klemm P, Rees AJ, Kerjaschki D: Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 2008, 14:1088-1096
26. Bacon PA: The spectrum of Wegener's granulomatosis and disease relapse. N Engl J Med 2005, 352:330-332
27. Falk RJ, Terrell RS, Charles LA, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990, 87:4115-4119
28. Falk RJ, Jennette JC: ANCA are pathogenic - oh yes they are! J Am Soc Nephrol 2002, 13:1977-1979
29. Csernok E, Ai M, Gross WL, Wicklein D, Petersen A, Lindner B, Lamprecht P, Holle JU, Hellmich B: Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Blood 2006, 107:4440-4448
30. Voswinkel J, Mueller A, Kraemer JA, Lamprecht P, Herlyn K, Holl-Ulrich K, Feller AC, Pitann S, Gause A, Gross WL: B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 2006, 65:859-864
31. Gilligan HM, Bredy B, Brady HR, Hebert MJ, Slayter HS, Xu Y, Rauch J, Shia MA, Koh JS, Levine JS: Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 1996, 184:2231-2241
32. Yang JJ, Tuttle RH, Hogan SL, Taylor JG, Phillips BD, Falk RJ, Jennette JC: Target antigens for anti-neutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils. Clin Exp Immunol 2000, 121:165-172
33. Lamprecht P, Mueller A, Gross WL: CD28-T cells display features of effector memory T cells in Wegener's granulomatosis. Kidney Int 2004, 65:1113; author reply 1113-1114
34. - T cells are a major source of interferon-γ and tumor necrosis factor-α in Wegener's granulomatosis. Am J Pathol 2002, 160:1717-1724
35. Day CJ, Hewins P, Savage CO: New developments in the pathogenesis of ANCA-associated vasculitis. Clin Exp Rheumatol 2003, 21:S35-S48
36. Clayton AR, Prue RL, Harper L, Drayson MT, Savage CO: Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits CD40, CD80, and CD86 expression and reduces allogeneic T cell responses: relevance to systemic vasculitis. Arthritis Rheum 2003, 48:2362-2374
37. Heeringa P, Tervaert JW: Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic? Kidney Int 2004, 65: 1564-1567
38. Kamesh L, Harper L, Savage CO: ANCA-positive vasculitis. J Am Soc Nephrol 2002, 13:1953-1960
39. Williams JM, Kamesh L, Savage CO: Translating basic science into patient therapy for ANCA-associated small vessel vasculitis. Clin Sci (Lond) 2005, 108:101-112
40. Williams JM, Ben-Smith A, Hewins P, Dove SK, Hughes P, McEwan R, Wakelam MJ, Savage CO: Activation of the Gi heterotrimeric G protein by ANCA IgG F(ab′)2 fragments is necessary but not sufficient to stimulate the recruitment of those downstream mediators used by intact ANCA IgG. J Am Soc Nephrol 2003, 14:661-669
41. ras activation in neutrophils by antineutrophil cytoplasm antibodies. J Am Soc Nephrol 2005, 16:90-96
42. Abdel-Salam B, Iking-Konert C, Schneider M, Andrassy K, Hansch GM: Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood. Kidney Int 2004, 66:1009-1017
43. Specks U: Antineutrophil cytoplasmic antibodies: are they pathogenic? Clin Exp Rheumatol 2004, 22:S7-S12
44. Tse WY, Nash GB, Hewins P, Savage CO, Adu D: ANCA-induced neutrophil F-actin polymerization: implications for microvascular inflammation. Kidney Int 2005, 67:130-139
45. Steiner K, Moosig F, Csernok E, Selleng K, Gross WL, Fleischer B, Broker BM: Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis. Clin Exp Immunol 2001, 126:143-150
46. Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG: CD4-positive effector memory T cells participate in disease expression in ANCA-associated vasculitis. Ann NY Acad Sci 2007, 1107:22-31
47. Marinaki S, Kalsch AI, Grimminger P, Breedijk A, Birck R, Schmitt WH, Weiss C, van der Woude FJ, Yard BA: Persistent T-cell activation and clinical correlations in patients with ANCA-associated systemic vasculitis. Nephrol Dial Transplant 2006, 21:1825-1832
48. Abrams JR, Kelley SL, Hayes E, Kikuchi T, Brown MJ, Kang S, Lebwohl MG, Guzzo CA, Jegasothy BV, Linsley PS, Krueger JG: Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J Exp Med 2000, 192:681-694
49. Müschen M, Warskulat U, Perniok A, Even J, Moers C, Kismet B, Temizkan N, Simon D, Schneider M, Haussinger D: Involvement of soluble CD95 in Churg-Strauss syndrome. Am J Pathol 1999, 155:915-925
50. Mitsuyama H, Matsuyama W, Watanabe M, Shirahama Y, Higashimoto I, Wada T, Osame M, Arimura K: Increased expression of TRAIL receptor 3 on eosinophils in Churg-Strauss syndrome. Arthritis Rheum 2007, 56:662-673
51. Matsuyama W, Mitsuyama H, Ono M, Shirahama Y, Higashimoto I, Osame M, Arimura K: Discoidin domain receptor 1 contributes to eosinophil survival in an NF-κB-dependent manner in Churg-Strauss syndrome. Blood 2007, 109:22-30
52. Peen E, Hahn P, Lauwers G, Williams RC Jr, Gleich G, Kephart GM: Churg-Strauss syndrome: localization of eosinophil major basic protein in damaged tissues. Arthritis Rheum 2000, 43:1897-1900
53. Higashi N, Mita H, Taniguchi M, Turikisawa N, Higashi A, Ozawa Y, Tohma S, Arimura K, Akiyama K: Urinary eicosanoid and tyrosine derivative concentrations in patients with vasculitides. J Allergy Clin Immunol 2004, 114:1353-1358
54. Guilpain P, Auclair JF, Tamby MC, Servettaz A, Mahr A, Weill B, Guillevin L, Mouthon L: Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome. Ann NY Acad Sci 2007, 1107:392-399
55. Pendergraft WF 3rd, Preston GA, Shah RR, Tropsha A, Carter CW Jr, Jennette JC, Falk RJ: Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004, 10:72-79
56. Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG: Trimethoprim- sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996, 335:16-20
57. Kain R, Matsui K, Exner M, Binder S, Schaffner G, Sommer EM, Kerjaschki D: A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells. J Exp Med 1995, 181:585-597
58. Bosch X, Guilabert A, Espinosa G, Mirapeix E: Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo? Trends Immunol 2008, 29:280-289
59. Eisenberger U, Fakhouri F, Vanhille P, Beaufils H, Mahr A, Guillevin L, Lesavre P, Noel LH: ANCA-negative pauci-immune renal vasculitis: histology and outcome. Nephrol Dial Transplant 2005, 20:1392-1399
60. Cunningham MA, Huang XR, Dowling JP, Tipping PG, Holdsworth SR: Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis. J Am Soc Nephrol 1999, 10:499-506
61. Carrie S, Fenton PA: Necrobacillosis - an unusual case of pharyngotonsillitis. J Laryngol Otol 1994, 108:1097-1098
62. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R: EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009, 68:310-317